HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Kari Hemminki Selected Research

digalactosylglucosylceramide

6/2006Polymorphisms in the growth hormone receptor: a case-control study in breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Kari Hemminki Research Topics

Disease

64Neoplasms (Cancer)
08/2015 - 03/2002
39Breast Neoplasms (Breast Cancer)
07/2015 - 03/2002
19Melanoma (Melanoma, Malignant)
11/2015 - 03/2002
18Colorectal Neoplasms (Colorectal Cancer)
06/2014 - 10/2006
9Chromosome Aberrations (Chromosome Abnormalities)
11/2015 - 10/2002
8Urinary Bladder Neoplasms (Bladder Cancer)
09/2011 - 01/2003
6Neoplasm Metastasis (Metastasis)
01/2014 - 05/2005
6Basal Cell Carcinoma (Rodent Ulcer)
05/2012 - 07/2005
5Carcinoma (Carcinomatosis)
10/2015 - 02/2002
5Prostatic Neoplasms (Prostate Cancer)
01/2013 - 01/2006
5Lung Neoplasms (Lung Cancer)
02/2009 - 04/2002
4Skin Neoplasms (Skin Cancer)
11/2015 - 05/2003
4Chromosomal Instability (Chromosome Stability)
01/2012 - 04/2009
4Kidney Neoplasms (Kidney Cancer)
07/2007 - 09/2005
3Mesothelioma
03/2015 - 04/2003
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2015 - 04/2002
3Genetic Predisposition to Disease (Genetic Predisposition)
05/2012 - 08/2006
3Infection
01/2012 - 10/2009
3Adenocarcinoma
09/2011 - 07/2005
2Papillary Carcinoma
03/2015 - 11/2011
2Multiple Myeloma
01/2015 - 05/2012
2Obesity
06/2014 - 06/2009
2Amyloidosis
01/2013 - 01/2012
2Leukemia
01/2012 - 11/2005
2Inflammation
01/2011 - 06/2008
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
07/2009 - 09/2008
2Asbestosis
02/2009 - 03/2005
2Non-Hodgkin Lymphoma (Lymphosarcoma)
04/2008 - 08/2006
2Second Primary Neoplasms (Neoplasms, Second)
04/2007 - 03/2007
2Epilepsy (Aura)
08/2006 - 01/2006
2Xeroderma Pigmentosum (Kaposi's Disease)
05/2004 - 04/2002
2Nevus (Nevi)
02/2004 - 01/2002
2Pigmented Nevus (Melanocytic Nevus)
05/2002 - 03/2002
1Pain (Aches)
12/2015
1Autoimmune Diseases (Autoimmune Disease)
12/2015
1Renal Cell Carcinoma (Grawitz Tumor)
05/2015
1Large Cell Carcinoma
03/2015
1Signet Ring Cell Carcinoma
03/2015
1Seminoma
03/2015
1Transitional Cell Carcinoma
03/2015
1Meningioma (Meningiomas)
03/2015

Drug/Important Bio-Agent (IBA)

17DNA (Deoxyribonucleic Acid)IBA
11/2015 - 03/2002
8Telomerase (Telomerase Reverse Transcriptase)IBA
10/2015 - 04/2009
8Estrogens (Estrogen)FDA Link
01/2014 - 05/2005
8Codon (Codons)IBA
01/2013 - 08/2002
7HormonesIBA
01/2013 - 09/2007
6MicroRNAs (MicroRNA)IBA
06/2011 - 03/2008
5Proteins (Proteins, Gene)IBA
01/2013 - 03/2006
53' Untranslated Regions (3' UTR)IBA
01/2013 - 03/2003
4Insulin (Novolin)FDA Link
08/2015 - 12/2004
4Biological Markers (Surrogate Marker)IBA
06/2014 - 03/2005
4CarcinogensIBA
11/2013 - 11/2004
4ORALIT (ORS)IBA
01/2013 - 11/2007
4Carbon MonoxideIBA
07/2012 - 01/2006
4EnzymesIBA
09/2011 - 01/2004
3Progesterone Receptors (Progesterone Receptor)IBA
07/2015 - 05/2005
3Nasopharyngeal carcinomaIBA
03/2015 - 04/2007
3Transforming Growth Factor beta (TGF-beta)IBA
03/2010 - 10/2004
3Transforming Growth Factor beta1 (TGF beta 1)IBA
03/2010 - 10/2004
3AsbestosIBA
02/2009 - 04/2003
3Cyclin-Dependent Kinase Inhibitor p16IBA
04/2007 - 04/2002
3TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
10/2006 - 11/2005
3Tumor Suppressor Protein p14ARF (p14ARF)IBA
01/2006 - 04/2002
3DNA AdductsIBA
01/2004 - 04/2002
2Ternary Complex FactorsIBA
02/2014 - 10/2013
2InterferonsIBA
01/2014 - 01/2012
2SteroidsIBA
01/2014 - 08/2002
2CytokinesIBA
12/2013 - 12/2011
2Toll-Like Receptors (Toll-Like Receptor)IBA
12/2013 - 01/2011
2Interleukin-6 (Interleukin 6)IBA
12/2013 - 10/2009
2Gonadal Steroid Hormones (Sex Hormones)IBA
01/2013 - 10/2012
2Aromatase (CYP19)IBA
01/2013 - 10/2012
2ProgesteroneFDA LinkGeneric
01/2013 - 10/2012
2Prostate-Specific Antigen (Semenogelase)IBA
11/2012 - 01/2006
2ArsenicIBA
05/2012 - 08/2006
2Transcription Factors (Transcription Factor)IBA
02/2012 - 01/2006
2Calcibiotic Root Canal SealerIBA
01/2012 - 07/2005
2Ovarian epithelial cancerIBA
09/2011 - 01/2008
2Folic Acid (Vitamin M)FDA LinkGeneric
03/2011 - 07/2005
2Vitamin DFDA LinkGeneric
11/2010 - 07/2007
2Cyclin D1IBA
10/2009 - 05/2004
2Type 1 Melanocortin ReceptorIBA
10/2009 - 04/2008
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2009 - 09/2007
2SmokeIBA
05/2008 - 04/2002
2Phosphotransferases (Kinase)IBA
02/2007 - 01/2007
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2007 - 05/2005
2TamoxifenFDA LinkGeneric
11/2006 - 03/2005
2IronIBA
11/2005 - 07/2005
2papillary Thyroid cancerIBA
10/2005 - 01/2003
2Styrene (Styrol)IBA
06/2004 - 10/2002
2Pyrimidine DimersIBA
03/2002 - 01/2002
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
12/2015
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
12/2015
1diphthamideIBA
11/2015
1Proto-Oncogene Proteins c-etsIBA
11/2015
1NAD (NADH)IBA
11/2015
1Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA
10/2015

Therapy/Procedure

5Drug Therapy (Chemotherapy)
09/2011 - 03/2007
2Length of Stay
07/2012 - 03/2011
2Combination Drug Therapy (Combination Chemotherapy)
09/2011 - 04/2007